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University, SingaporeABSTRACT Acyl carrier protein (ACP) domains shuttle acyl intermediates among the catalytic domains of multidomain type I
fatty acid synthase and polyketide synthase (PKS) systems. It is believed that the unique function of ACPs is associated with
their dynamic property, but it remains to be fully elucidated what type of protein dynamics is critical for the shuttling domain.
Using NMR techniques, we found that the ACP domain of iterative type I PKS CalE8 fromMicromonospora echinospora is highly
dynamic on the millisecond-second timescale. Introduction of an interhelical disulfide linkage in the ACP domain suppresses the
dynamics on the millisecond-second timescale and reduces the mobility on the picosecond-nanosecond timescale. We demon-
strate that the full-length PKS is fully functional upon rigidification of the ACP domain, suggesting that although the flexibility of
the disordered terminal linkers may be important for the function of the ACP domain, the internal dynamics of the helical regions
is not critical for that function.INTRODUCTIONFatty acid synthases (FAS) and polyketide synthases (PKS)
are divided into type I and type II systems (1,2). Type I
systems are large, highly integrated modular proteins, and
type II systems consist of small, discrete proteins. In
general, a type I PKS module consists of ketosynthase
(KS), acyltransferase (AT), acyl carrier protein (ACP), ke-
toreductase (KR), enoyl reductase (ER), and dehydratase
(DH). These domains are involved in the following chain-
elongation, modification, and termination steps during
biosynthesis: AT loads the starter/intermediate and extender
units (acetate, malonate, or propionate) to ACP and KS,
respectively; KS catalyzes the Claisen condensation
between the extender unit and the growing chain; and the
keto-ester intermediate is then modified by the optional
reductive components (ER, KR, and DH). During these
processes, the growing polyketide intermediate is covalently
tethered to the ACP domain via a thioester linkage and shut-
tled among the catalytic domains. The mature polyketide
intermediate is usually off-loaded by a thioesterase to
release the polyketide product. The number and combina-
tion of catalytic domains vary significantly among different
PKSs. For the iterative type I PKS CalE8 containing six
domains, ACP is located between AT and KR (Fig. 1 a).
ACPs play a central role in both FAS and PKS systems in
the production of fatty acids and a wealth of secondary
metabolites (1). ACPs are small (~9 kDa) monomeric
domains and proteins in type I and II FAS/PKS systems,
respectively (1,3). Although different ACPs have a low
sequence identity, they adopt a canonical structure with
three or four a-helices and contain a conserved serineSubmitted June 7, 2012, and accepted for publication August 2, 2012.
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serves to attach acyl intermediates (4). Also, they are highly
conserved in the function of shuttling the intermediates
among various partner enzymes or catalytic domains.
Before an ACP can perform its function, it is first activated
by ACP synthase or 40-phosphopantetheinyl transferase (40-
PPTase), which attaches a phosphopantetheine group from
coenzyme A (CoA) onto the conserved serine of ACP to
tether the acyl intermediate as thiol ester. The activated
ACP that carries the acyl intermediates interacts with
different catalytic domains in the same protein for the
type I system or with discrete enzymes for the type II system
at different stages during biosynthesis (1,3).
The ability of ACPs to be recognized by a series of
proteins and shuttling among different catalytic domains is
believed to be associated with their dynamic property
(4,5). Indeed, ACPs have been shown to be highly dynamic.
The isolated type I ACP domain from rat is flexible in its N-
and C-terminal regions, as well as in one of the loops (6).
The ACP domain in the full-length yeast FAS has been
proposed to function like a swinging arm, and its structure
solved by x-ray crystallography has been suggested to repre-
sent a single conformation adopted by the FAS, indicating
the flexibility of the ACP domain (7,8). For type II ACPs,
dynamics on a wide range of timescales have been observed
(9–12), but different ACPs display different dynamic
features. Some type II ACPs, such as those from Escherichia
coli, spinach, and parasite, exist in equilibrium between two
states (12–14), but it is unclear whether the conformational
exchange is relevant to ACP’s function. Although many type
II ACPs are folded at neutral pH, some ACPs reported from
Helicobacter pylori (hpACP) and Vibrio harveyi (vhACP)
are so mobile that they adopt a mainly disordered conforma-
tion in the absence of Mg2þ at neutral pH (15,16). However,http://dx.doi.org/10.1016/j.bpj.2012.08.006
FIGURE 1 (a) Domain organization of CalE8
and ribbon structure of meACP, with S971,
A938C, and E1009C highlighted. (b) Thermal
denaturation profiles of meACP and its mutant
monitored at 222 nm by CD. (c) CD profiles of
meACP and its mutant with and without 1.7 mM
TCEP at 25C.
1038 Lim et al.such high mobility or disorder does not seem to be critical to
ACP’s function, because vhACP and its cyclic form are
equally functional even though the latter adopts a folded
conformation (17). In addition, for the structurally and func-
tionally similar peptidyl carrier protein (PCP) domain in the
nonribosomal peptide synthetase (NRPS), apo-PCP and
holo-PCP each exist in two slowly exchanging conforma-
tions and they share a common conformation (18). This
conformational diversity has been shown to be important
for the interactions of apo-PCP and holo-PCP with exter-
nally acting proteins such as 40-PPTase and thioesterases.
The conformational exchange also provides insight into
the directed phosphopantetheine movement required for
delivering substrates to upstream and downstream catalytic
domains (18). However, the two observed holo-conforma-
tions could not explain how holo-PCP can recognize at least
three partners (e.g., thioesterase, adenylation domain, and
condensation domain) during biosynthesis.
Recently, we solved the solution structure of the ACP
domain of iterative type I PKS CalE8 fromMicromonospora
echinospora spp. calichensis (meACP), which is composed
of a single module consisting of six catalytic domains for
the synthesis of the putative precursor of the 10-member
enediyne moiety (19). We showed that meACP is highly
dynamic on a timescale of seconds, although the helices
are quite rigid on the picosecond-nanosecond timescaleBiophysical Journal 103(5) 1037–1044(19,20). Nevertheless, it is presently unclear whether the
intrinsic flexibility is crucial for the shuttling of the ACP
domain to perform its function within the compartmental-
ized chamber of the iterative PKS system. Here we demon-
strate that we can dramatically reduce the internal dynamics
of meACP by introducing a disulfide linkage between
helices 1 and 3, and that the dynamics of the structural
region of the ACP domain on the picosecond-nanosecond
and microsecond-second timescales is not critical for the
function and activity of the iterative PKS CalE8.MATERIALS AND METHODS
Samples preparation
We performed site-directed mutagenesis for meACP and CalE8 using Pfu
(Promega) and KOD Hot Start (Novagen) DNA polymerases, respectively,
after Dpn1 digestion (Stratagene) and DNA gel electrophoresis purification.
BL21 DH5a cell transformation was used to amplify the PCR product,
which was later confirmed by sequencing. meACP and CalE8 and their
mutants were prepared according to previously described protocols
(19,21,22). Coexpression of CalE8 and thioesterase CalE7 were performed
as previously described (23).Circular dichroism spectroscopy
Circular dichroism (CD) spectra were recorded on a Jasco J-810 spectropo-
larimeter equipped with a thermal controller. For disulfide bond reduction,
ACP Dynamics and Its Functional Role 103930 mM of protein was preincubated with 1.7 mM tris(2-carboxyethyl)phos-
phine (TCEP) for 10 min or 10 mM dithiothreitol (DTT) for 4 hr in 20 mM
phosphate and 50 mM NaCl at pH 6.9, 25C. Thermal unfolding was moni-
tored at 222 nm in samples containing 30 mM protein, 20 mM phosphate,
and 50 mM NaCl at pH 6.9.NMR spectroscopy
All NMR experiments were performed on an 800 MHz NMR spectrometer
equipped with a cryoprobe at 25C, using 15N-labeled samples containing
0.5 mM protein in 20 mM sodium phosphate buffer at pH 6.9, 50 mM
NaCl. For hydrogen-deuterium (H-D) exchange experiments, the samples
were lyophilized and then resuspended in D2O. Three-dimensional (3D)
15N-edited total correlation spectroscopy (TOCSY) and nuclear Overhauser
spectroscopy (NOESY) experiments were performed with mixing times of
65 and 80 ms, respectively. Heteronuclear 15N-{1H} NOEs were measured
using two spectra without and with proton saturation with a saturation delay
of 4 s and recycle delay of 4 s by the inverse-detected 2D NMR method.
Proton saturation was achieved by a train of 120 pulses spaced at 5 ms.
Relaxation dispersion data were collected on both 500 and 800 MHz
NMR spectrometers as described previously (24). In the presence of a series
of Carr-Purcell-Meiboom-Gill (CPMG) fields (field strengths: 40, 80, 120,
160, 200, 240, 320, 400, 480, 560, 640, 720, 800 and 960 Hz), the apparent
relaxation rates were measured using a constant time delay (TCP ¼ 50 ms)
and interscan delay of 2 s. Dispersion curves were subsequently fitted with
a two-site exchange model to extract kinetics parameters (25).
We measured the amide hydrogen exchange rates using a previously
described pulse scheme (20) with an interscan delay of 2 s and 16 mixing
times (20, 30, 40, 50, 60, 70, 80, 90, 100, 120, 140, 160, 190, 220, 260, and
300 ms). We recorded the reference spectrum used in the amide exchange
measurement with a long interscan delay of 12 s. We measured the H-D
exchange rates by monitoring the dependence of the 1H-15N HSQC peak
intensities on the time after resuspending the lyophilized samples in D2O.CalE8 enzymatic assay
The enzymatic reactions for CalE8 were monitored with a UV-Vis spectro-
photometer (22). A typical reaction contained 2.3 mg/ml CalE8 protein,
3.3 mg/ml CalE7, and 0.25 mM NADPH in a 100 mM HEPES buffer
(pH 8.5) in a total volume of 200 ml. The absorption at 340 nm was auto-
zeroed before addition of the substrate malonyl-CoA. Immediately after
the addition of 1 mM malonyl-CoA, we recorded the progress of the reac-
tion by following the absorption change at 340 nm. For the enzymatic reac-
tions in the presence of TCEP, the reaction mixture was preincubated with
5 mM TCEP for 5–10 min before the addition of NADPH to initiate the
reaction.RESULTS AND DISCUSSION
Stabilization of meACP by a disulfide linkage
On the basis of the meACP structure (PDB ID: 2L9F), all
cysteine candidates for potential disulfide linkages were
identified and tested for protein expression and stability.
In this study, we found that a disulfide linkage was success-
fully introduced by mutating A938 and E1009 into cyste-
ines. Both A938 and E1009 are located far away from the
conserved active serine residue (Ser-971) and their Cbs are
in close proximity (<4 A˚; Fig. 1 a). We expect that the
cysteine mutant expressed in E. coli can form an intramolec-
ular disulfide bond through thiol oxidation by O2 dissolved
in the buffer. It is noteworthy that the wild-type (WT)meACP contains no cysteine residues. The formation of
the expected disulfide bond was confirmed by mass spec-
trometry study of the mutant in the absence and presence
of the reducing agent, DTT (see Fig. S1 in the Supporting
Material). Moreover, thermal denaturation revealed that
this mutant has remarkable thermostability relative to the
WT meACP (Tm was increased by 33
C from ~52C to
85C; Fig. 1 b). In the presence of TCEP (a more stable
and effective reducing agent than DTT), the Tm of the
mutant was nearly the same as that of meACP, indicating
that the significant increase in stability is indeed caused
by the formation of a disulfide instead of the simple
A938C/E1009C mutation effect. Interestingly, the Tm of
the WT meACP was ~10C higher in the presence of
TCEP than in the absence of TCEP, suggesting that TCEP
can stabilize meACP. In comparison, DTT has no stabilizing
effect on meACP (Fig. S2).Structure of the stabilized meACP mutant
CD spectroscopy shows that the A938C/E1009C mutation
has little effect on the secondary structure profile of meACP
(Fig. 1 c). Using 3D 15N-edited TOCSYand NOESY, and the
previous assignments of WT meACP, we assigned 1HN,
15N,
and aliphatic 1HC spins and obtained
1HN-
1HC and
1HN-
1HN
NOEs for the meACP mutant. The short- and medium-range
NOE patterns (Fig. 2) and chemical shift index (Fig. S3)
confirm that the secondary structure is barely influenced by
the mutation, consistent with the CD results. Residues
N995–A997 in front of the third helix may form a 310 helix
in the mutant based on the medium-range NOEs and chem-
ical shift index. The long-range NOEs observed in the
mutant sample are consistent with the 3D structure of the
WT meACP, demonstrating that the mutation does not
change the tertiary structure significantly. However, the pres-
ence of a number of extra long-range NOEs in the mutant
(L939Hb-E1006HN and V942Hg-L1008HN (which are
close to the disulfide linkage), A947Hb-L952HN, L964Hd-
S970HN, L977Hd-A950HN, A982Hb-L987HN, A982Hb-
V990HN, T998Ha-E1003HN, T1000Ha-S961HN, and
V1001Hg-R962HN) suggests that the mutant is more stable
than theWTmeACP, consistent with the Tm result. Similarly
to meACP, the mutant gave rise to only one set of NMR
signals, indicating that both theWTandmutantmeACP exist
in a single major conformation.Dynamics on the picosecond-nanosecond
timescale
Heteronuclear 15N-{1H} NOE is very sensitive to the local
mobility of an amide NH on the picosecond-nanosecond
timescale.meACP and its mutant show similar heteronuclear
NOE profiles (Fig. 3).Similar to type I rat ACP (6), only the
disordered terminal regions are very flexible. The average
NOEs of the helices, loop 1, and loop 2 were respectivelyBiophysical Journal 103(5) 1037–1044
FIGURE 2 Sequential- and medium-range NOE
patterns of the meACP mutant. The NOE intensi-
ties are represented by the thickness of the solid
bars. The secondary structure elements of the
WT protein are indicated at the top of the
sequence.
1040 Lim et al.0.75, 0.73, and 0.64 for the WT meACP, and 0.80, 0.79, and
0.68 for the mutant. The middle region of loop 2 had an
average NOE value of 0.59 for both the WT and mutant
meACP. Similar to other globular proteins, the helical regions
are quite rigid. Interestingly, loop 1 between helices 1 and 2 is
as rigid as the helices, whereas the middle region of loop 2 is
less rigid. Because the difference of the average NOEs (0.04)
between theWTandmutant proteins ismarginally larger than
the average error (0.02), overall the mutant is slightly more
rigid on the picosecond-nanosecond timescale.Dynamics on microsecond-millisecond timescale
To investigate the dynamics on microsecond-millisecond
timescale, we performed relaxation dispersion experiments.FIGURE 3 Comparison of 15N-{1H} NOEs for WT meACP () and its
mutant (B). The locations of two cysteine residues in the mutant are indi-
cated by arrows on the secondary structure diagram.
Biophysical Journal 103(5) 1037–1044The contribution of conformational exchange to 15N trans-
verse relaxation (Rex) was estimated from relaxation rates
(R2
eff) measured at CPMG field strengths of 40 and
960 Hz on an 800 MHz NMR spectrometer, Rex ¼
Reff2 ðnCP; 40HzÞ  Reff2 ðnCP; 960HzÞ (26). For meACP
(A925 – H1017), 74 out of 86 amides that were not overlap-
ped and had good signal/noise (S/N) ratios displayed Rex-
values in the range of 1–11 s1, and 12 other residues that
were mainly located in the disordered N-terminal region
had Rex < 1 s
1. To obtain reliable conformational
exchange parameters, we employed only residues that had
Rex > 2 s
1 at both 500 and 800 MHz NMR to fit to
a two-state theoretical model (25), which involved 58 amino
acids distributing in three helices and two loops. The data
were simultaneously fitted well to the model by a single
set of exchange parameters (Fig. 4, a–e), indicating that
meACP likely exists in two states in solution. The exchange
rate between the two states was found to be 301 5 3 s1,
and the populations of the major and minor states were
96.6% and 3.4%, respectively.
Due to the very low population of the minor form, the 15N
chemical shifts of the major state (dma) were considered to
be the same as those observed in the 1H-15N HSQC spec-
trum. The 15N chemical shifts of the minor state (dmi)
were calculated from dma and the shift differences between
the two states (D), which were extracted from the fitting of
the relaxation dispersion data. Because the sign of Dwas not
determined, we obtained two possible dmi values for each
15N spin: dma þ D and dma  D. For a given amide 15N,
the dmi value close to the random coil
15N chemical shift
was considered to be the shift of the minor form. The
random coil shifts used here were corrected for the
sequence-dependent effects (27). The relatively good corre-
lation between the dmi values and random coil shifts
(Fig. 4 f) suggests that the invisible minor state likely exists
in a partially disordered state. Also, it is possible that there
FIGURE 4 Representative relaxation dispersion
profiles of meACP (a–e) and comparison of exper-
imental (dmi) and random coil (drandom)
15N chem-
ical shifts of the invisible minor form (f). The
experimental data recorded by 500 and 800 MHz
NMR are indicated by B and *, respectively,
and solid lines are fitting curves in panels a–e.
ACP Dynamics and Its Functional Role 1041are two or more minor forms that exchange with one another
as well as with the major form.
In contrast to the WT meACP, the mutant displayed no
relaxation dispersion for nearly all residues (Fig. S4, a–e).
Only four residues (C938, R958, D960, and L967) had
detectable Rex (1–2 s
1) on an 800 MHz NMR (Fig. S4 f).
C938 is located at the beginning of helix 1, and R958,
D960, and L967 are located in loop 1. The small Rex likely
resulted from local conformational exchange rather than
global structural changes. The results demonstrate that the
mutant is much more rigid than the WT protein on the
microsecond-millisecond timescale.Dynamics on the second timescale
Recently, we measured the amide hydrogen exchange rates
(kex) of the WT meACP and determined the protection (P)
factors of amides (20). The average kex values for the resi-
dues in the three helices (excluding the three amides at
the N-terminus of each helix, which are normally not
involved in H-bonding), were ~0.4 s1 at pH 6.9, and the
average P factor was ~25. However, here we found that
the kex values for most residues in the structural regions of
the mutant were too small (<0.1 s1) to be detected
by the amide hydrogen exchange experiment. To determine
the dynamics of the mutant on the second timescale, we per-
formed H-D exchange experiments. In contrast to the WT
meACP, in which amide protons were completely
exchanged into deuterons within the NMR dead time
(~3 min), the mutant was resistant to the H-D exchange,
especially for the amides in the helices. The average kex
value (at pH 6.9) and P factor for the helical residueswere 6  104 s1 and 2  104, respectively, which are
changed by >600-fold compared with the result of the
WT meACP (Fig. 5). The results demonstrate that the
mutant is much more rigid than the WT meACP on
the second timescale.The rigidified meACP domain retains its
biological activity
Having established that the introduced disulfide linkage
significantly reduces the internal flexibility of meACP, we
set out to test whether the reduced flexibility affects the
function of the full-length PKS (CalE8). The A938C/
E1009C mutation was introduced into the full-length
CalE8 gene by site-directed mutagenesis. After overexpres-
sion in E. coli, the recombinant WT and mutant CalE8 were
purified to homogeneity. The purified proteins exhibited
bright yellow coloration with a broad absorbance around
400 nm (Fig. 6 a). It has been shown that the absorbance
is attributed to the PKS-tethered polyene products synthe-
sized in E. coli (21,22). This observation indicates that the
mutant protein is enzymatically active and functional in
E. coli cells. The result implies that the cysteine residues
in the mutant CalE8 do not pair wrongly with the cysteine
residues in other domains that contain 18 cysteine residues.
Otherwise, the ACP domain would be permanently fixed at
one or two domains through the incorrect interdomain disul-
fide linkages and would not be able to move to the catalytic
centers in other domains. In addition, the two cysteine resi-
dues in the ACP domain of the mutant CalE8 should form an
intradomain disulfide bond, as demonstrated in the isolated
meACP mutant (note that the two cysteine residues are inBiophysical Journal 103(5) 1037–1044
FIGURE 5 Comparison of P factors for WT (bar) and mutant (*)meACP.
P factors were calculated from amide hydrogen exchange rates (kex) and
random coil exchange rates. For theWTmeACP, kex values were previously
measured at pH 6.9 and 7.5 using an exchange spectroscopy (EXSY)
scheme. For the mutant, kex values were obtained using either the EXSY
scheme or the H-D exchange method. When P < 100 or log(P) < 2, kex
could be measured using the EXSY scheme. When P > 1000 or log(P) >
3, kex could be measured using the H-D exchange scheme. When 100 <
P < 1000, kex could not be measured by these two methods. The locations
of two cysteine residues in the mutant are indicated by arrows on the
secondary structure diagram.
1042 Lim et al.close proximity). To further evaluate the effect of the disul-
fide linkage on PKS activity, we performed in vitro assays.
The WTand mutant CalE8 were coexpressed with thioester-
ase CalE7 to remove the covalently linked PKS products
from the CalE8 (23). The proteins were purified without
adding reducing agent in the lysis and purification buffer,
and further exposed to air for several hours to ensure the
formation of the disulfide linkage. The product-free PKS
proteins were assayed for their enzymatic activity by
absorption spectroscopy. By monitoring the consumptionFIGURE 6 Enzymatic activity of CalE8 and the double mutant. (A)
Absorption spectra of the WT and mutant CalE8 expressed from E. coli.
(B and C) Comparison of the enzymatic activity of CalE8 and the double
mutant under (B) oxidizing and (C) reducing conditions.
Biophysical Journal 103(5) 1037–1044of the substrate NADPH, we found that the WT and mutant
CalE8 exhibited nearly identical enzymatic efficiency
(Fig. 6 b). After the disulfide bond in PKS CalE8 was
reduced by preincubating the enzymes with TCEP, the
mutant CalE8 exhibited slightly lower enzymatic efficiency
(Fig. 6 c). Together, these results suggest that the reduced
internal dynamics in the ACP domain has little effect on
the overall activity of the iterative PKS CalE8.Are the observed ACP dynamics critical for ACP
function?
Different ACPs with low sequence identity adopt a very
similar overall structure (4) but display very different
dynamics over a wide range of timescales. The type I PKS
meACP shown here is quite rigid on the picosecond-nano-
second timescale, except for the middle region of loop 2
and two terminal regions. The entire WT meACP is very
dynamic on the millisecond-second timescale and it may
exist in two conformations (one major and one minor
form) that undergo intermediate exchange in the NMR
time regime. The type I FAS apo-ACP from rat is mobile
on the picosecond-nanosecond timescale only for the two
terminal regions and the middle region of loop 1 instead
of loop 2 (6). The rat apo-ACP domain exists in a single
folded form and is quite rigid on the microsecond-milli-
second timescale, except for Asp-2150 adjacent to Ser-
2151, which is the phosphopantetheine attachment site (6).
This is dramatically different from the type I meACP.
For type II oxytetracycline apo-ACP, loop 1 is flexible on
the picosecond-nanosecond timescale and helix 2 (the
proposed recognition region) is mobile on the micro-
second-millisecond timescale (9). For type II frenolicin
holo-ACP, loop 1 is mobile on the picosecond-nanosecond
timescale but the short helix 30 is mobile on the micro-
second-millisecond timescale (10). Helix 30 is absent in
most of the frenolicin ACP NMR structures and completely
absent in meACP. Type II spinach FAS apo- and holo-ACPs
(28,29) each exist in two forms that are in slow exchange,
and one of the forms is largely unfolded. Type II E. coli
ACP (ecACP) also exists in two forms, but the two forms
are in fast exchange (12,13). Although two conformational
states were observed for the holo-ACP from Plasmodium
falciparum (14) and holo-ACP from Mycobacterium
tuberculosis (30), they are caused by the reorientation of
the phosphopantetheine prosthetic group rather than the
intrinsic dynamics of the proteins. Most amide protons
located in the helices of ecACP are protected from H-D
exchange (P factor > 1000) (11), implying rigidity on the
second timescale, whereas the amide protons in meACP
are poorly protected (P factor < 80) (20). Type II vhACP
is unfolded in the absence of divalent ions, but it becomes
folded in the presence of Mg2þ or Ca2þ (16,31). Because
the basal level of Mg2þ is 1–2 mM in bacteria (32), vhACP
should function in a folded state in vivo.
ACP Dynamics and Its Functional Role 1043A recent study on type II spinach ACP showed that the
protein dynamics are influenced by the length of the fatty
acids that are attached to the protein (33). Actually, this is
reasonable because the fatty acid chain is sequestered by
the hydrophobic cavity in type II ACPs (28). In contrast to
type II ACPs, the type I ACP domains do not interact with
either the fatty acid chain or the phosphopantetheine pros-
thetic group (6,19). Thus, we expect that the acylation of
type I ACPs does not affect the dynamics of the protein.
Because all ACPs perform the same function, i.e., shuttling
acyl intermediates to a series of partners during biosyn-
thesis, the dramatically varied dynamics among different
ACPs should not correlate with their function. Our mutant
and WT CalE8 enzymes have the same biological activities,
demonstrating that the intrinsic dynamics of the structural
region (A938-R1013 for meACP) of type I ACP on
the picosecond-nanosecond, microsecond-millisecond, and
second timescales are not critical for its function.
For the meACP construct used here (A925 – H1017), the
14 N-terminal residues and four C-terminal residues are
unstructured and flexible (Figs. 2 and 3). In CalE8, ~50 resi-
dues preceding the first helix and ~40 residues following the
last helix of meACP domain were predicted to be unstruc-
tured (Fig. S5). Very likely, these residues form two long
flexible linkers that permit meACP to shuttle among
different catalytic domains in a swinging manner. Recently,
a swinging model was proposed for the delivery of
substrates by ACP to different catalytic domains in the yeast
FAS system, where the N-terminal region (136 residues) of
the ACP domain is flexible and its C-terminus is connected
to the center of the FAS particle through a flexible hinge
with ~60 residues (7).CONCLUSION
In summary, we found that the ACP domain of the iterative
type I PKS CalE8 is highly dynamic on the millisecond-
second timescale in the region that encompasses the three
helices, loop 2, and loop 1 that is near the active serine.
The mutant with a disulfide linkage between helices 1 and
3 is more rigid on the same timescale and much more stable
against thermal denaturation, whereas its flexibility is only
slightly lower than that of the WT meACP on the pico-
second-nanosecond timescale. Despite the significant reduc-
tion in the flexibility of the ACP domain, the full-length
CalE8 mutant is fully active and capable of synthesizing
the PKS products at the same rate as the WT enzyme.
Hence, the internal dynamics of the structural region of
meACP does not seem to be critical for the function of the
iterative PKS CalE8 and probably many other iterative
PKSs. Nonetheless, the disordered terminal regions are flex-
ible and may be important for the function of type I ACPs,
which are connected to the two flanking catalytic domains.
In addition, we cannot exclude the possibility that ACP’s
dynamics on the nanosecond-microsecond timescale, whichwas undetectable in our NMR experiments, is necessary for
function.SUPPORTING MATERIAL
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